Press release
Global Neutropenia Drugs Market, Size, Share, Analysis Report & Forecast to 2026
The Global neutropenia drugs market is anticipated to grow at a CAGR of 5.0% during the forecast period. The major factors for growth of the market include the increasing prevalence of cancer cases along with increasing investment in R&D by companies, to develop various novel therapies for the treatment of this disease, which will fuel the growth of the market during the forecast period.Free Sample Copy @ https://www.omrglobal.com/request-sample/neutropenia-drugs-market
Neutropenia is a disease where the number of white blood cells (neutrophils) present in the blood are reduced significantly, further hampering the immune system of the patient. In 2019, 9.8 million new cancer patients received chemotherapy treatment, according to the Lancet Oncology journal. The chemotherapy affects the count of WBCs, as some of them die during the treatment. This aspect will further grow the demand of the market during the forecast period. According to the WHO around more than 15 million patients will go under chemotherapy treatment by 2040.
A Full Report of Global Neutropenia Drugs Market is Available at:
https://www.omrglobal.com/industry-reports/neutropenia-drugs-market
According to the International Agency for Research on Cancer, in 2018, 169,270 people were living with leukemia and 58,876 new leukemia cases were diagnosed in North America. In February 2018, Partner Therapeutics, a Boston-based cancer company, acquired Leukine (Sargramostim) from Sanofi for $60 million, which is used for the treatment of leukemia. Some of the key global players in theneutropenia drugs marketinclude Teva Pharmaceutical, Amgen, Sanofi, Mylan, Kyowa Kirin, Baxter International, and many others.
Global Neutropenia Drugs Market – Segmentation
By Treatment
Colony-stimulation factor
Antibiotics
Antifungal
Antiviral
By Distribution Channels
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Neutropenia Drugs Market – Segmentation by Region
North America
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Company Profiles
Teva Pharmaceutical
Amgen
Sanofi
Mylan
Kyowa Kirin
Baxter International
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/neutropenia-drugs-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Neutropenia Drugs Market, Size, Share, Analysis Report & Forecast to 2026 here
News-ID: 2428973 • Views: …
More Releases from Orion Market Research
Wearable Injectors Market Size, Trends, Latest Insights, Analysis and Forecast 2 …
The global wearable injectors market is anticipated to grow at a considerable CAGR of 11.8% during the forecast period. The key factors that are contributing to the market growth are the increasing adoption of several strategies adopted by key players operating the market such as new technology-based product development, new plant setup, acquisition, mergers, and collaboration among other. Tus attributed to it to expand globally and remain competitive in the…
Urgent Care Center Market Size, Trends, Latest Insights, Analysis and Forecast 2 …
The global urgent care center market is anticipated to grow at a considerable CAGR of 4.3% during the forecast period. One of the key factors contributing to the market growth includes the increasing adoption of several strategies such as global expansion, new product launches, partnerships, collaboration, and mergers among others by the key market players. For instance,
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/urgent-care-center-market
• In June 2022,…
Teleradiology Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2 …
The global teleradiology market is anticipated to grow at a considerable CAGR of 14.7% during the forecast period. The key factors that are contributing to the market growth are increasing funding activity and new product development with innovation and integration of technology into products, and new services being implemented are such factors that drive teleradiology market growth. For instance,
• In December 2020, 5C Network has received funding of $1.2 Million…
Teledentistry Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2 …
The global teledentistry market is anticipated to grow at a considerable CAGR of 15.7% during the forecast period. The key factors that are contributing to the market growth are the increasing adoption of various strategies such as acquisition, mergers, and collaboration, among others by a prominent player in the teledentistry market. For instance,
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/teledentistry-market
• In January 2022, Grin partnered with…
More Releases for Neutropenia
Expected growth of Chemotherapy Induced Neutropenia Market in 2027
The Chemotherapy Induced Neutropenia Market report offers a deep analysis of the Chemotherapy Induced Neutropenia trade. It demonstrates a quick outline of trade knowledge and key Information like Key Manufacturers , Types, Application, Table Of Content, etc of the market. The report highlights Top Venders from the worldwide and Chemotherapy Induced Neutropenia Market along with their worth of the Industry to see their progress. The worldwide Chemotherapy Induced Neutropenia analysis…
Neutropenia Assessment and Therapeutics Pipeline Review H1 2018
Summary
Neutropenia is an abnormally low count of neutrophils, a type of white blood cell that helps fight off infections, particularly those caused by bacteria and fungi. Signs and symptoms include fevers, frequent infections, mouth ulcers, gum infections and dysuria.
Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Neutropenia - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Neutropenia (Hematological Disorders), complete with analysis by stage of development,…
Chemotherapy Induced Neutropenia Market Report by MarketResearchReports.biz
"The Latest Research Report Chemotherapy Induced Neutropenia-Pipeline Review, H1 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chemotherapy Induced Neutropenia - Pipeline Review, H1 2018, provides an overview of the Chemotherapy Induced Neutropenia (Toxicology) pipeline landscape.
Chemotherapy-induced neutropenia is a very common side effect of cancer treatment. Symptoms include severe fatigue, weakness,…
New Report Examines the Febrile Neutropenia Market Research
Febrile neutropenia is defined as the development of fever with sign of infection. Febrile neutropenia is one of the most severe complications during cancer chemotherapy and is mainly caused by infectious agents like gram positive and gram negative bacteria. This diseased condition significantly reduces white blood cell count of the patients. Blood test is helpful to determine the number of white blood cells and to diagnose febrile neutropenia disease. Additionally,…
Global Chemotherapy-Induced Neutropenia Treatment Market 2017: Beneficial Applic …
Qyresearchreports include new market research report Global Chemotherapy-Induced Neutropenia Treatment Market Professional Survey Report 2017 to its huge collection of research reports.
This report on the global Chemotherapy-Induced Neutropenia Treatment market, is compiled by a group of market research analysis professionals aims to act as a credible business material for shareholders. The report represents the current market scenario and the future prospects as well. Proven research methodologies have been used in…
Global Market Study On Neutropenia Pipeline Review, H2 2017
"The Report Neutropenia - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neutropenia - Pipeline Review, H2 2017, provides an overview of the Neutropenia (Hematological Disorders) pipeline landscape.
Neutropenia is an abnormally low count of neutrophils, a type of white blood cell that helps fight off infections, particularly those…
